The modern marketing maze

Marketing in our industry is not for the faint-hearted, although it is an area where dynamic teams can discover communicative muscles they never knew they had. As digital possibilities emerge at pace, the modern marketing maze offers exciting opportunities, but identifying them amid regulation and digital domination presents a formidable set of challenges. Challenges which, curiously, many relish...
Pharmaceutical pricing - it’s political

Dr Joe Zammit-Lucia on why it is becoming increasingly import for pharma companies to develop new approaches to pricing that have political resonance
The Plan in action

Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the seismic changes that have been occurring in the NHS since the Long Term Plan was published

News

View all

Animal experiment stats show reluctance to embrace modern tools

A shockingly high number of dogs, mice, cats, rabbits and other animals are still suffering in invasive, painful and sometimes lethal experiments in British laboratories.

19th July 2019

Bayer, BMS, Ono team up to investigate Stivarga, Opdivo combo

Encouraging early data have been seen with the studied combination, as in a Phase Ib investigator sponsored trial from Japan called REGONIVO

19th July 2019

Robots to help produce new class of antibiotics

The antibiotics, known as class II polyketides, are also naturally produced by soil bacteria and have antimicrobial properties.

19th July 2019

Boehringer expands IPF pipeline with addition of BBT-877

Under the terms of the deal Bridge Biotherapeutics will receive upfront and near term payments of EUR 45million and is eligible to receive up to more than EUR 1.1billion in potential payments.

19th July 2019

Mallinckrodt halts mid-stage Acthar trial citing pneumonia risk

ALS is a progressive neurodegenerative disease that affects motor neuron cells in the brain and the spinal cord.

19th July 2019

Web Exclusives

View all

Why the ‘total talent’ approach wins in Life Science

Cielo's Tanya Derrick says building a sustainable talent strategy is key to addressing recruitment challenges in the life sciences industry

Partnering for a global healthcare ecosystem

Prof Sudhesh Kumar, dean of the Warwick Medical School and board member of NHS Digital, on Japan’s ageing society and the lessons for the UK healthcare market

Getting more from less

Organisational psychologist Jane Piper on why we should be doing less to achieve more

Taking a wider look at early-stage research

The lack of availability of early-stage research, particularly in online repositories, threatens to hinder scientific progress, says Morressier's Sami Benchekroun

Magazine

View more from the latest edition

Patient Files: prostate cancer

Chris James shares his experiences with different treatments for testicular and prostate cancer

Thumbnail image for SmartPeople: James Merson

James Merson, global therapeutic area head for Infectious Diseases at Janssen Research & Development, believes that through continued advancements in science “we can change the trajectory of health for humanity and strive to make infectious diseases an issue of the past”

Pharmaceutical pricing - it’s political

Dr Joe Zammit-Lucia on why it is becoming increasingly import for pharma companies to develop new approaches to pricing that have political resonance

Company Focus: MedPharm

Jeremy Drummond, senior vice president of Business Development at MedPharm, on the challenges and opportunities of topical delivery

Connected labelling - the final frontier?

However much progress life sciences companies have made in bringing their regulatory information under control, labelling management continues to overshadow these accomplishments. Too often labelling is disconnected from other systems, forcing heavy reliance on manual processes and checks which in turn can cause hold-ups and create an undesirable source of risk, especially across country borders. Agnes Cwienczek delves deeper into the issues and potential remedies

The modern marketing maze

Marketing in our industry is not for the faint-hearted, although it is an area where dynamic teams can discover communicative muscles they never knew they had. As digital possibilities emerge at pace, the modern marketing maze offers exciting opportunities, but identifying them amid regulation and digital domination presents a formidable set of challenges. Challenges which, curiously, many relish...

The promised land?

Brexit was supposed to be an opportunity for the UK to strike trade deals outside the EU, but the going is tough

A true partnership

Michael Goetzl says it’s time for industry to work in true partnership with health systems “at every step of the way” to speed up access to innovation